Therapeutic Asset Ratings
176 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Etb-Dualnk-01 Metastatic Prostate Carcinoma | Beijing Biotech | P1 | C (37) |
Showing 176 to 176 of 176 assets